Assessing Integrated Nucleic Acids in Engineered Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing genomic integration of transgene sequences in genetically engineered cells, particularly for adoptive cell therapies, lack accuracy and efficiency, especially in early stages or non-expanded processes, leading to potential overestimation of integrated sequences due to the inclusion of non-integrated residual nucleic acids.
Innovation Solution
The method involves separating a high molecular weight fraction of DNA (>10 kilobases) from engineered cells using techniques like pulse field gel electrophoresis, followed by quantitative analysis to distinguish integrated from non-integrated transgene sequences, allowing for precise determination of copy numbers and avoiding false positives.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to assess transgene copy number, then the assessment includes all nucleic acid sequences, but non-integrated residual nucleic acids cause overestimation and reduce measurement precision
Solution Approach 1:
The method segments the total nucleic acid population by separating integrated transgene sequences (high molecular weight, >10kb) from non-integrated residual nucleic acids (low molecular weight) through size-based fractionation techniques such as pulsed-field gel electrophoresis or size exclusion chromatography, enabling precise quantification of only the integrated portion
Solution Approach 2:
The method extracts and isolates the high molecular weight fraction containing integrated transgene sequences from the total DNA sample, removing the contaminating low molecular weight non-integrated nucleic acids that would otherwise cause overestimation in copy number assessments
2Measurement precision
If separation techniques are applied to isolate high molecular weight fraction, then measurement precision improves, but device complexity and process difficulty increase
Solution Approach 1:
The method employs pulsed-field gel electrophoresis or size exclusion chromatography as intermediary separation techniques that utilize molecular size differences to fractionate DNA populations, serving as a bridge between total DNA extraction and precise quantification of integrated sequences without requiring overly complex specialized equipment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables accurate and reliable assessment of integrated transgene sequences, reducing false positives and overestimation, thereby improving the characterization and safety of engineered cells for therapeutic use.
Implementation Method 1
separating a high molecular weight fraction of deoxyribonucleic acid (DNA) of greater than or greater than about 10 kilobases (kb) from DNA isolated from one or more cell
Data Source
AI summary
Provided are methods for assessing nucleic acid sequences integrated into a genome of a genetically engineered cell, such as a genetically engineered cell used in cell therapy. Cells are generally genetically engineered to express a recombinant protein, such as a recombinant receptor, via introduction of a polynucleotide and integration of certain sequences in the polynucleotide, such as recombinant sequences, into the genome of the cell. In some aspects, the provided methods can be used to distinguish integrated nucleic acids and non-integrated, residual nucleic acids.